Radiation lethality potentiation in total body irradiated mice by a commonly prescribed proton pump inhibitor, Pantoprazole sodium

References

• Agastya G, West BC, Callahan JM. 2000. Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro. Immunopharmacol Immunotoxicol 22:357–372.
   PubMed Web of Science ®Google Scholar
• Baker DE. 2006. Intravenous proton pump inhibitors. Rev Gastroenterolog Disord 6:22–34.
   PubMedGoogle Scholar
• Berkey FJ. 2010. Managing the adverse effects of radiation therapy. Am Family Physician 82:381–388,394.
   PubMed Web of Science ®Google Scholar
• Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Baldavs ZG, Dunn JR, Gould H, MacCannell DR, Gerding DN, McDonald LC, Lessa FC. 2013. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA 173:1359–1367.
   Google Scholar
• Dinsmore JE, Jackson RJ, Smith SD. 1997. The protective role of gastric acidity in neonatal bacterial translocation. J Pediatric Surg 32: 1014–1016.
   PubMed Web of Science ®Google Scholar
• Fried M, Siegrist H, Frei R, Froehlich F, Duroux P, Thorens J, Blum A, Bille J, Gonvers JJ, Gyr K. 1994. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut 35:23–26
   PubMed Web of Science ®Google Scholar
• Goddard AF, Spiller RC. 1996. The effect of omeprazole on gastric juice viscosity, pH and bacterial counts. Aliment Pharmacol Therapeut 10:105–109.
   PubMed Web of Science ®Google Scholar
• Graham DY, Genta RM. 2008. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep 10:543–547.
   PubMedGoogle Scholar
• Gupta PK, Brown J, Biju PG, Thaden J, Deutz NE, Kumar S, Hauer-Jensen M, Hendrickson HP. 2011. Development of high-throughput HILIC-MS/MS methodology for plasma citrulline determination in multiple species. Analyt Meth 3:1759–1768.
   Web of Science ®Google Scholar
• Hopkins AM, McDonnell C, Breslin NP, O’Morain CA, Baird AW. 2002. Omeprazole increases permeability across isolated rat gastric mucosa pre-treated with an acid secretagogue. J Pharm Pharmacol 54:341–347.
   PubMed Web of Science ®Google Scholar
• Kanno T, Matsuki T, Oka M, Utsonumiya H, Inada K, Magari H, Inoue I, Maekita , Ueda K, Enomoto S, Iguchi M, Yanaoka K, Amai H, Akimoto S, Nomoto K, Tanaka R, Ichinose M. 2009. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 381:666–670.
   PubMed Web of Science ®Google Scholar
• Lai KC, Lam SK, Chu KM, Hue WM, Kwok KR, Wong BC, Hu HC, Wong WM, Chan OO, Chan CK. 2003. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users – a randomized trial. Aliment Pharmacol Therapeut 18:829–836.
   PubMed Web of Science ®Google Scholar
• Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M. 1996. Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncologica 35:81–87.
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Franco S, Young G, O’Keefe SJ. 1996. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Therapeut 10:557–561.
   PubMed Web of Science ®Google Scholar
• Palileo C, Kaunitz JD. 2011. Gastrointestinal defense mechanisms. Curr Opin Gastroenterol 27:543–548.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Urban JL, Knight LC, Brown KL, Trate DM, Miller MA, Maurer AH, Fisher RS. 1998. Effect of gastric acid suppressants on human gastric motility. Gut 42:243–250.
   PubMed Web of Science ®Google Scholar
• Reilly TG, Grimley CE, Usselmann B, Cottrel J, Mann SG, Raskin S, Nwokolo CU. 1998. Low-dose famotidine and effervescent cimetidine in healthy subjects: A placebo-controlled overnight pH study. Aliment Phamacol Therapeut 12:469–474.
   PubMed Web of Science ®Google Scholar
• Sachs G, Shin JM. 2004. The basis of differentiation of PPI. Drugs of Today (Barcelona, Spain) 40(Suppl. A):9–14.
   PubMed Web of Science ®Google Scholar
• Sfakianakis G, Sfakianaki E. 2007. The sodium-iodine symporter and the proton-pump inhibitors in – related to the side effects of – the treatment of thyroid cancer with iodine-131. Hellenic J Nuclear Med 10:2–5.
   PubMed Web of Science ®Google Scholar
• Shin JM, Sachs G. 2004. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo. Biochem Pharmacol 68:2117–2127.
   PubMed Web of Science ®Google Scholar
• Steer CB, Harper PG. 2002. Gastro-oesophageal complications in patients receiving cancer therapy: The role of proton pump inhibitors. Eur J Gastroenterol Hepatol 14(Suppl. 1):S17–21.
   Google Scholar
• Stiefel U, Rao A, Pultz MJ, Jump RLP, Aron DC, Donskey CJ. 2006. Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by Vancomycin- resistant Enterococcus spp. and Klebsiella pneumoniae in Clindamycin-treated mice. Antimicrob Agents Chemother 50:3905–3907.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Mori M, Miura S, Suematsu M, Fukumura D, Kimura H, Ishii H. 1996. Omeprazole attenuates oxygen-derived free radical production from human neutrophils. Free Rad Biol Med 21:727–731.
   PubMed Web of Science ®Google Scholar
• Tennant SM, Hartland EL, Phumoonna T, Lyras D, Rood JI, Robins-Browne RM, van Driel IR. 2008. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immunity 76:639–645.
   PubMed Web of Science ®Google Scholar
• Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, Gonvers JJ, Fried M. 1996. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: A prospective randomised double blind study. Gut 39:54–59.
   PubMed Web of Science ®Google Scholar
• Tutuian R, Katz PO, Bochenek W, Castell DO. 2002. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Aliment Pharmacol Therapeut 16:829–836.
   PubMed Web of Science ®Google Scholar
• Wendall JH. 1992. Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245. Gut 33:617–621.
   PubMed Web of Science ®Google Scholar
• Withers HR, Elkind MM. 1970. Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation. Int J Radiat Biol Rel Stud Phys, Chem Med 17:261–267.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, Kondo M. 2000. A new mechanism for anti-inflammatory actions of proton pump inhibitors – inhibitory effects on neutrophilendothelial cell interactions. Aliment Pharmacol Therapeut 14(Suppl. 1):74–81.
   PubMed Web of Science ®Google Scholar
• Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. 2002. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 30:1118–1122.
   PubMed Web of Science ®Google Scholar
• Zvyaga T, Chang SY, Chen C. Yang Z, Vuppugalla R, Hurley J, Thorndike D, Wagner A, Chimalakonda A, Rodrigues AD. 2012. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: Focus on cytochrome P450 2C19. Drug Metabol Disposit 40:1698–1711.
   PubMed Web of Science ®Google Scholar